PATENT CLAIM ANALYSIS

Application Number: 15936515
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "443000"]

Abstract:
Transdermal administration system comprising doxofylline as the active ingredient, for use in the treatment of bronchopulmonary diseases having a broncho-obstructive component.

Claim (Index 15):
The method of  claim 14 , wherein the transdermal patch matrix polymer is selected from the group consisting of an acrylic polymer, a silicone)polymer, and a styrene block copolymer.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.04545
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16090593', '13064334', '13791460', '12823448', '10631539']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7302356149369913
- 35 USC 102 Novelty (BERT): 0.4799933449537723
- Combined Prediction Score: 0.7052113879386693
- Mean Citation Score: 133.7345128
- Max Citation Score: 161.28572
- Similarity Product: 110.99135238630772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test